The increased use of semaglutide drugs like Ozempic and Wegovy among teenagers raises concerns about the long-term effects, prompting calls for comprehensive studies.
Pediatricians are observing significant health changes among teens treated with semaglutide, but experts highlight uncertainties regarding the drugs' impact on critical aspects like growth and puberty.
There's a growing realization that the relationship between weight and health is intricate, with some individuals classified as obese still being metabolically healthy, prompting a reassessment of treatment approaches.
The trend of prescribing lifelong medications like semaglutide to teens for weight management invokes ethical questions, emphasizing the need to understand potential long-term consequences for this vulnerable age group.
Collection
[
|
...
]